Agomab Therapeutics Is A Biotechnology Company Located In Ghentbelgiumdedicated To Developing Innovativetreatments For Fibrotic Diseasesthecompany Focuses On Preserving And Restoring Organ Function By Utilizing Its Expertisein Growth Factor Biologyparticularly Through Thetransforming Growth Factor Betatgfi And Hepatocytegrowth Factorhgfsignaling Pathways Founded On Theresearch Of Drpaolo Michieliagomab Is Creating Agonistic Monoclonal Antibodiesknown Asagomabs To Mimic Theeffects Of Hgfwhich Is Essential For Cell Proliferation And Tissueregenerationthecompany Is Building A Pipelineof Therapies Aimed At Resolving Fibrosis And Repairing Tissuestructurewith Thepotential To Address Various Fibroticinflammatoryautoimmuneand Degenerativeconditionsagomab Has Established Significant Partnershipsincluding Onewith Argenxto Enhanceits Development Of Hgf Mimetic Antibodiestheleadership Teamunder Ceo Tim Knotnerusis Committed To Improving Patient Outcomes Through Collaboration And Innovativescience
No conferences found for this company.
| Company Name | Agomab Spain Slu |
| Country |
Spain
|
| Address | N/A |
| Telephone | N/A |
| N/A |
